Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Clark Sisodia, M.D.

Concepts (247)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genital Neoplasms, Female1020245363.060 Why?
Fallopian Tube Neoplasms520223291.770 Why?
Ovarian Neoplasms19202349151.710 Why?
Carcinoma, Endometrioid920232751.380 Why?
Vulvar Neoplasms420242661.040 Why?
Peritoneal Neoplasms520237070.980 Why?
Endometrial Neoplasms11202313820.920 Why?
Hysterectomy620228630.790 Why?
Carcinosarcoma620231080.780 Why?
Anesthesia Department, Hospital12021690.710 Why?
Uterine Neoplasms8202314240.650 Why?
Sexual Dysfunction, Physiological120213640.600 Why?
Neoplasms, Glandular and Epithelial320154890.580 Why?
Genetic Counseling120206350.520 Why?
Physicians, Primary Care120216240.460 Why?
Social Support1202321930.420 Why?
Psychometrics2202130620.410 Why?
Electronic Health Records5202248840.400 Why?
Adenocarcinoma, Clear Cell320232180.400 Why?
Cystadenocarcinoma, Serous520234800.400 Why?
Fallopian Tubes220221790.390 Why?
Lymph Node Excision7202312690.380 Why?
Pelvis420237360.360 Why?
Data Collection1202033250.360 Why?
Anesthesiology1202111370.350 Why?
Healthcare Disparities2202334150.350 Why?
Uterine Cervical Neoplasms4202320430.320 Why?
Menotropins12008410.310 Why?
Quality of Life82023134890.310 Why?
Neoplasms, Cystic, Mucinous, and Serous220151950.310 Why?
Female6120243971020.300 Why?
Ovary220229650.300 Why?
Ovarian Follicle120082440.270 Why?
Anxiety1202146720.270 Why?
Ovulation Induction120082770.260 Why?
Follicle Stimulating Hormone120087270.260 Why?
Humans7320247679980.240 Why?
Massachusetts4202388930.240 Why?
Neoplasm Staging182023112210.240 Why?
Antineoplastic Combined Chemotherapy Protocols82023118740.220 Why?
SEER Program10201614440.220 Why?
Lymph Nodes4202134720.220 Why?
Cystadenocarcinoma, Papillary12023560.220 Why?
Health Status Indicators220219690.210 Why?
Middle Aged3220232234220.200 Why?
Fallopian Tube Diseases12022600.200 Why?
Delivery of Health Care1202053660.200 Why?
Carcinoma1201323300.190 Why?
Teratoma120144050.190 Why?
Aged3120231714530.190 Why?
Osteoarthritis, Knee2202212510.190 Why?
Pandemics1202187500.190 Why?
Ovarian Diseases120221360.180 Why?
Arthroplasty, Replacement, Knee2202213890.180 Why?
Morpholines120145840.180 Why?
Sentinel Lymph Node Biopsy220227360.170 Why?
Metrorrhagia12010170.170 Why?
Surgical Procedures, Operative2202219320.170 Why?
Retrospective Studies222023817480.170 Why?
Chemotherapy, Adjuvant5202335530.170 Why?
Aminopyridines120145800.170 Why?
Receptors, N-Methyl-D-Aspartate120149030.160 Why?
Medical Oncology3201923410.160 Why?
Aged, 80 and over152023596000.160 Why?
Patient Readmission1201332890.160 Why?
Health Education1201510590.160 Why?
Neoplasm, Residual2202110140.150 Why?
Genetic Predisposition to Disease12020180690.150 Why?
Hydatidiform Mole120102550.150 Why?
Osteoarthritis, Hip120224090.150 Why?
Attitude of Health Personnel2202239300.140 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120213880.140 Why?
Health Facilities120225780.140 Why?
Specialties, Surgical120223910.140 Why?
Maternal Age120108050.140 Why?
Neoplasm Recurrence, Local4202194120.140 Why?
Risk Adjustment120205980.140 Why?
Referral and Consultation3202036190.130 Why?
Activities of Daily Living2202224290.130 Why?
Prospective Studies52023549210.120 Why?
Postoperative Care1202214800.120 Why?
Proto-Oncogene Proteins c-akt1201424560.120 Why?
Adult1920232235770.120 Why?
Gynecologic Surgical Procedures220152870.120 Why?
TOR Serine-Threonine Kinases1201420610.120 Why?
Burnout, Professional120237110.120 Why?
Lymphatic Metastasis5202229080.120 Why?
Precancerous Conditions120219840.110 Why?
Disability Evaluation1202118350.110 Why?
Immunity, Cellular1201015610.110 Why?
Neoadjuvant Therapy4202329030.110 Why?
Survival Rate102016128270.110 Why?
Patient Positioning120163320.110 Why?
Kaplan-Meier Estimate7201665170.110 Why?
Academic Medical Centers2202227830.110 Why?
Program Evaluation1202225060.110 Why?
Myometrium120141740.110 Why?
Ileus12013650.110 Why?
Placenta Accreta120162420.100 Why?
Intraoperative Care120167680.100 Why?
Epithelial Cells1201437030.100 Why?
Video Recording120179760.100 Why?
Self Care120177990.100 Why?
Perioperative Period120132520.100 Why?
Adenocarcinoma, Mucinous120165240.100 Why?
Patient Acceptance of Health Care1201532310.100 Why?
Cohort Studies52022417530.090 Why?
Early Detection of Cancer1201532380.090 Why?
Length of Stay4202264950.090 Why?
Health Knowledge, Attitudes, Practice1201540550.090 Why?
Leiomyosarcoma120154260.090 Why?
Carcinoma, Transitional Cell220167940.090 Why?
Education, Medical, Graduate1201224210.090 Why?
Sarcoma1202118040.090 Why?
Developing Countries1201229140.090 Why?
Pleural Effusion120133440.080 Why?
Proportional Hazards Models72016125360.080 Why?
Radiotherapy, Adjuvant1201517880.080 Why?
Diagnostic Errors1201612800.080 Why?
Analgesics, Opioid2202338400.080 Why?
Gynecology120155340.080 Why?
Hospitals1202238870.080 Why?
Radiology1202221040.080 Why?
Clomiphene12008720.080 Why?
Combined Modality Therapy5201785360.080 Why?
Fertility Agents, Female120081010.070 Why?
Carcinoma, Papillary120137920.070 Why?
Intraoperative Complications1201411710.070 Why?
Opioid-Related Disorders1202321880.070 Why?
Disease-Free Survival4201668430.070 Why?
Carcinoma, Squamous Cell2201340500.070 Why?
Carboplatin220167910.070 Why?
Pregnancy, Multiple120082160.070 Why?
Health Personnel1202133870.070 Why?
Prognosis92016299840.070 Why?
Patient Education as Topic1201723370.070 Why?
Paclitaxel2201417280.070 Why?
Patients220239080.070 Why?
Image Enhancement1201628800.060 Why?
Luteinizing Hormone120088220.060 Why?
Patient Discharge2202334760.060 Why?
Physicians1202345980.060 Why?
Pregnancy Rate120086550.060 Why?
Postoperative Period2202218250.060 Why?
Decision Support Techniques1201420080.060 Why?
Platinum Compounds12014940.060 Why?
Radiotherapy3201615010.060 Why?
Surgical Wound Infection1201315460.060 Why?
Paget Disease, Extramammary12024500.060 Why?
United States112023730330.050 Why?
Phosphatidylinositol 3-Kinase120141250.050 Why?
Morphine Derivatives12023430.050 Why?
Neoplasm Invasiveness3201636180.050 Why?
Young Adult42023600500.050 Why?
Organoplatinum Compounds220154060.050 Why?
Treatment Outcome52021653600.050 Why?
Pregnancy52019302440.050 Why?
Reoperation1201343290.050 Why?
Population Groups120232090.050 Why?
Venous Thromboembolism1201518830.050 Why?
Mortality1201329110.050 Why?
Pain, Postoperative2202317680.050 Why?
Adenocarcinoma2202463720.050 Why?
Hydromorphone12022700.050 Why?
Genes, BRCA1120147550.050 Why?
Decompression12020360.050 Why?
Qualitative Research2202231410.050 Why?
Signal Transduction12014236400.040 Why?
Endometrial Hyperplasia120211020.040 Why?
Electrocoagulation120201560.040 Why?
Multivariate Analysis22014120750.040 Why?
Pulmonary Embolism1201325990.040 Why?
Job Satisfaction120235480.040 Why?
Class I Phosphatidylinositol 3-Kinases120149040.040 Why?
Papillomavirus Vaccines120154970.040 Why?
Suction120202680.040 Why?
Health Priorities120223800.040 Why?
Mice, SCID1201426270.040 Why?
PTEN Phosphohydrolase1201411200.040 Why?
Time Factors32015402100.040 Why?
Postoperative Complications22021158310.030 Why?
New England1201010580.030 Why?
Aminopterin12016150.030 Why?
Parity120109310.030 Why?
Aftercare120239160.030 Why?
Cell Count1201018310.030 Why?
Algorithms12016141630.030 Why?
Carcinoma in Situ120217880.030 Why?
Xenograft Model Antitumor Assays1201436090.030 Why?
Germ-Line Mutation1202318850.030 Why?
Laparotomy120174590.030 Why?
Phosphatidylinositol 3-Kinases1201428840.030 Why?
Remission Induction1201024090.030 Why?
Lower Extremity1202212170.030 Why?
Intraoperative Period120155120.030 Why?
Fellowships and Scholarships1201211350.030 Why?
Follow-Up Studies42016393400.030 Why?
Papillomavirus Infections1201516400.030 Why?
Guidelines as Topic1202013960.030 Why?
Age Factors32015184050.030 Why?
Knee Joint1202216830.030 Why?
Drug Resistance, Neoplasm2202153350.030 Why?
Myocardial Infarction12013115190.020 Why?
Tissue Distribution1201622990.020 Why?
Odds Ratio1202396670.020 Why?
Reproducibility of Results22021202180.020 Why?
Immunohistochemistry12014110680.020 Why?
Male420233646380.020 Why?
Feasibility Studies1202253140.020 Why?
Blood Loss, Surgical120146420.020 Why?
Emotions1202227660.020 Why?
Neutropenia120158920.020 Why?
Logistic Models22014132890.020 Why?
Contrast Media1202253310.020 Why?
Magnetic Resonance Imaging12016367430.020 Why?
Heart Failure12013118840.020 Why?
Low Back Pain120179900.020 Why?
Tumor Burden1201419040.020 Why?
Age Distribution1201328710.020 Why?
Drug Administration Schedule1201548570.020 Why?
Risk Assessment22021243170.020 Why?
Quality of Health Care1202243100.020 Why?
Medicare2201568140.020 Why?
Quality Improvement1202138560.020 Why?
Neoplasm Metastasis1201649040.020 Why?
Anemia1201515140.020 Why?
Laparoscopy1201720420.020 Why?
Antineoplastic Agents22015136580.010 Why?
Skin Neoplasms1202458610.010 Why?
Survival Analysis12017100960.010 Why?
Heart Rate1201442150.010 Why?
Risk1201496090.010 Why?
Health Status1201540920.010 Why?
Health Status Disparities1201318850.010 Why?
Sensitivity and Specificity12016147180.010 Why?
Diagnosis, Differential12016130000.010 Why?
Databases, Factual1201680820.010 Why?
Mutation12014302140.010 Why?
Blood Pressure1201485390.010 Why?
Tomography, X-Ray Computed12022207570.010 Why?
Breast Neoplasms12014212090.010 Why?
Registries1201383770.010 Why?
Mice12014820240.010 Why?
Incidence12015215330.010 Why?
Adolescent12014891540.010 Why?
Case-Control Studies12014222860.010 Why?
Animals120141692250.010 Why?
Sisodia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (247)
Explore
_
Co-Authors (92)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.